DAPK1 is associated with FTD and not with Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 32, Issue 1, 2012, Pages 13-17

  Tedde, Andrea ^a   Piaceri, Irene ^a   Bagnoli, Silvia ^a   Lucenteforte, Ersilia ^a   Piacentini, Silvia ^a   Sorbi, Sandro ^a   Nacmias, Benedetta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; DAPK1; frontotemporal dementia; SNP

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84867507175     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120556     Document Type: Article

References (19)

1. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90, 1977-1981.
2. Galimberti D, Scarpini E (2010) Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration. Int J Clin Exp Med 3, 129-143.
3. Zuchner S, Gilbert JR, Martin ER, Leon-Guerrero CR, Xu PT, Browning C, Bronson PG, Whitehead P, Schmechel DE, Haines JL, Pericak-Vance MA (2008) Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3. Ann Hum Genet 72, 725-731.
4. Pericak-Vance MA, Grubber J, Bailey LR, Hedges D,West S, Santoro L, Kemmerer B, Hall JL, Saunders AM, Roses AD, Small GW, Scott WK, Conneally PM, Vance JM, Haines JL (2000) Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 35, 1343-1352.
5. Curtis D, North BV, Sham PC (2001) A novel method of twolocus linkage analysis applied to a genome scan for late onset Alzheimer's disease. Ann Hum Genet 65, 473-481.
6. Myers A, Wavrant De-Vrieze F, Holmans P, Hamshere M, Crook R, Compton D, Marshall H, Meyer D, Shears S, Booth J, Ramic D, Knowles H, Morris JC, Williams N, Norton N, Abraham R, Kehoe P, Williams H, Rudrasingham V, Rice F, Giles P, Tunstall N, Jones L, Lovestone S, Williams J, Owen MJ, Hardy J, Goate A (2002) Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 114, 235-244.
7. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF,McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE, NIMH Genetics Initiative Alzheimer's Disease Study Group (2003) Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12, 23-32.
8. Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JS, Smemo S, Hinrichs A, Tacey K, Toombs TA, Kwok S, Catanese J, White TJ, Maxwell TJ, Hollingworth P, Abraham R, Rubinsztein DC, Brayne C,Wavrant-De Vrieze F, Hardy J, O'DonovanM, Lovestone S, Morris JC, Thal LJ, Owen M,Williams J, Goate A (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 15, 2560-2568.
9. Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, GoateAM(2009) Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta. Neurogenetics 10, 13-17.
10. Hainsworth AH, Allsopp RC, Jim A, Potter JF, Lowe J, Talbot CJ, Prettyman RJ (2010) Death-associated protein kinase (DAPK1) in cerebral cortex of late-onset Alzheimer's disease patients and aged controls. Neuropathol Appl Neurobiol 36, 17-24.
11. Minster RL, DeKosky ST, Kamboh MI (2009) No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease. Neurobiol Aging 30, 1890-1891.
12. Schjeide BM, McQueen MB, Mullin K, DiVito J, Hogan MF, ParkinsonM,Hooli B, Lange C, Blacker D,Tanzi RE, Bertram L (2009) Assessment of Alzheimer's disease case-control associations using family-based methods. Neurogenetics 10, 19-25.
13. Wu ZC, ZhangW,Yu JT, Zhang Q, TianY, Lu RC,Yu NN, Chi ZF, Tan L (2011) Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese. Brain Res 1374, 129-133.
14. The Dementia Study Group of the Italian Neurological Society (2000) Guidelines for the diagnosis of dementia and Alzheimer's disease. Neurol Sci 21, 187-194.
15. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders. DSM-IV, American Psychiatric Association, 4th edition, Washington, DC, USA, 1994.
16. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
17. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D,Trojanowski JQ,Work Group on Frontotemporal Dementia and Pick's Disease (2001) Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58, 1803-1809.
18. Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco L, Piacentini S, Amaducci L (1994) ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 177, 100-102.
19. Liu K, Muse SV (2005) PowerMaker: An integrated analysis environment for genetic maker analysis. Bioinformatics 21, 2128-2129.